These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 20114092

  • 1. Taking a lesson from microbial diarrheagenesis in the management of chronic constipation.
    Bharucha AE, Waldman SA.
    Gastroenterology; 2010 Mar; 138(3):813-7. PubMed ID: 20114092
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.
    Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
    [Abstract] [Full Text] [Related]

  • 3. Lubiprostone (Amitiza) for opioid-induced constipation.
    Med Lett Drugs Ther; 2013 Jun 10; 55(1418):47-8. PubMed ID: 24662842
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J.
    Expert Rev Gastroenterol Hepatol; 2013 Jul 10; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
    Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ.
    PLoS One; 2015 Jul 10; 10(7):e0134349. PubMed ID: 26222318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current and future therapies for chronic constipation.
    Tack J.
    Best Pract Res Clin Gastroenterol; 2011 Feb 10; 25(1):151-8. PubMed ID: 21382586
    [Abstract] [Full Text] [Related]

  • 12. Plecanatide Is Effective and Safe in the Treatment for Chronic Idiopathic Constipation: Results of a Phase II Trial.
    Barish C, Dorn S, Fogel RP, Patel R, Rosenberg J.
    Dig Dis Sci; 2021 Feb 10; 66(2):537-540. PubMed ID: 32185662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two randomized trials of linaclotide for chronic constipation.
    Lembo AJ, Schneier HA, Shiff SJ, Kurtz CB, MacDougall JE, Jia XD, Shao JZ, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Eng P, Fox SM, Johnston JM.
    N Engl J Med; 2011 Aug 11; 365(6):527-36. PubMed ID: 21830967
    [Abstract] [Full Text] [Related]

  • 15. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation.
    Vazquez Roque M, Camilleri M.
    Expert Rev Gastroenterol Hepatol; 2011 Jun 11; 5(3):301-10. PubMed ID: 21651347
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.
    Fukudo S, Endo Y, Hongo M, Nakajima A, Abe T, Kobayashi H, Nakata T, Nakajima T, Sameshima K, Kaku K, Mizagliflozin Study Group.
    Lancet Gastroenterol Hepatol; 2018 Sep 11; 3(9):603-613. PubMed ID: 30056028
    [Abstract] [Full Text] [Related]

  • 17. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
    Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H.
    Neurogastroenterol Motil; 2018 May 11; 30(5):e13275. PubMed ID: 29278278
    [Abstract] [Full Text] [Related]

  • 18. Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
    Chey WD, Lembo AJ, Rosenbaum DP.
    Am J Gastroenterol; 2017 May 11; 112(5):763-774. PubMed ID: 28244495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.